Vaxart, Inc.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet …
Biotechnology
US, South San Francisco [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Vaxart, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDVaxart, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Vaxart, Inc..
If you want to see a demo, head over to the financial segments of AAPL